Your browser doesn't support javascript.
loading
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
Ortiz-Prado, Esteban; Simbaña-Rivera, Katherine; Gómez-Barreno, Lenin; Rubio-Neira, Mario; Guaman, Linda P; Kyriakidis, Nikolaos C; Muslin, Claire; Jaramillo, Ana María Gómez; Barba-Ostria, Carlos; Cevallos-Robalino, Doménica; Sanches-SanMiguel, Hugo; Unigarro, Luis; Zalakeviciute, Rasa; Gadian, Naomi; López-Cortés, Andrés.
Affiliation
  • Ortiz-Prado E; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: e.ortizprado@gmail.com.
  • Simbaña-Rivera K; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: ksimbanarivera@gmail.com.
  • Gómez-Barreno L; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: lsgomezbarreno@gmail.com.
  • Rubio-Neira M; Hospital Baca Ortiz, Pediatric and Cardiology Department, Quito, Ecuador. Electronic address: drrubio24@yahoo.com.
  • Guaman LP; Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador. Electronic address: linda.guaman@ute.edu.ec.
  • Kyriakidis NC; Grupo de Investigación en Biotecnología Aplicada a Biomedicina (BIOMED), Universidad de la Americas, Quito, Ecuador. Electronic address: nikolaos.kyriakidis@udla.edu.ec.
  • Muslin C; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: claire.muslin@udla.edu.ec.
  • Jaramillo AMG; Faculty of Medicine, Pontificia Universidad Católica del Ecuador, Quito, Ecuador. Electronic address: mdanamagomez84@gmail.com.
  • Barba-Ostria C; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: carlos.barba.ostria@udla.edu.ec.
  • Cevallos-Robalino D; Intensive Care Unit, Hospital Quito Sur IESS, Quito, Ecuador. Electronic address: domecevallos.92@gmail.com.
  • Sanches-SanMiguel H; One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: hmssanmiguel@icloud.com.
  • Unigarro L; Intensive Care Unit, Hospital SOLCA Quito, Quito, Ecuador. Electronic address: luisunigarro3@gmail.com.
  • Zalakeviciute R; Grupo de Biodiversidad Medio Ambiente y Salud (BIOMAS), Universidad de Las Américas, Quito, Ecuador; Intelligent and Interactive Systems Lab (SI2 Lab) Universidad de Las Américas (UDLA), Quito, Ecuador. Electronic address: rasa.zalakeviciute@udla.edu.ec.
  • Gadian N; University of Southampton, Department of Public Health, Southampton, United Kingdome. Electronic address: naomigadian@hotmail.com.
  • López-Cortés A; Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador; Red Latinoamericana de Implementación y Validación de Guías Clínicas Farmacogenómicas (RELIVAF-CYTED), Quito, Ecuador. Electronic address: aalc84@gmail.com.
Diagn Microbiol Infect Dis ; 98(1): 115094, 2020 Sep.
Article in En | MEDLINE | ID: mdl-32623267
Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least 7 coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20 May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Diagn Microbiol Infect Dis Year: 2020 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Diagn Microbiol Infect Dis Year: 2020 Document type: Article Country of publication: United States